definiens: means ( a ) any single pharmaceutical product that contains both a GSK -3 Inhibitor and an HDAC Inhibitor, regardless of whether such GSK -3 Inhibitor and HDAC Inhibitor are the same or different compound(s ) or composition(s ) and regardless of whether alone or in c ombination with one or more other therapeutically active ingredients or ( b ) any group of two or more pharmaceutical products to be used as combination therapy ( i.e. one product is administered to a patient simultaneously with, or within a set period of tim e of, another product(s ) and sold for use as such combination therapy, whether sold individually or together ) which, among the group of products, contain a GSK -3 Inhibitor and an HDAC Inhibitor, in each case of clause ( a ) and ( b ), in any dosage form or for mulation, regardless of mode of administration . For clarity, Frequency ’s developmental product known as FX -322 shall be a Licensed Product